Long-acting injectable adoption remains low, but Indivior's market position, payer access and consumer campaign could help ...

There has been a substantial increase in recent years in the use of a form of primary medication to treat opioid use disorder ...

There was a substantial increase in recent years in the use of a form of the primary medication to treat opioid use disorder, ...

Novo Nordisk has recently demonstrated interest in the manufacture of GLP-1 implant that could keep delivering semaglutide ...

Long-acting injectables (LAIs) are sustained drug delivery systems specifically designed so that medication is released into the body gradually over an extended period of time. Image Credit: Powder ...

How is the long-acting injectable space evolving? As world populations get older and more people have access to healthcare, the need to develop therapies to treat chronic diseases increases.

Patients with HIV who were more impacted by health disparities were less likely to find long-acting injectable antiretroviral therapy appealing. LAI-ART is a novel tool that can be used to treat PWH ...

The federal Food and Drug Administration has approved Apretude (extended-release cabotegravir), the first long-acting injectable option for HIV prevention. The shots, which are administered by a ...

Aurobindo, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir, also CAB-LA, for HIV treatment in 133 countries, per The Hindu report. This follows ViiV ...

Real-world data suggest long-acting injectables may help achieve—not just maintain—viral suppression. Real-world data from the OPERA cohort are challenging long-standing assumptions about when ...

Please provide your email address to receive an email when new articles are posted on . Fewer than 2% of patients who received long-acting injectable antipsychotics were readmitted vs. 8.3% of those ...